In view of this, and the previous report of PCAL progression to an aggressive tumor, we assessed p16 immunoexpression and CDKN2A locus integrity using FISH analysis in this tumor and 4 cases of classical PCAL. This evidence concerns the gene CDKN2A and neoplasm.